Clinical study
Staphylococcus aureus bacteremia: Current clinical patterns☆

https://doi.org/10.1016/0002-9343(76)90715-4Get rights and content

Abstract

One hundred and five cases of bacteremia due to Staphylococcus aureus were reviewed to assess the current clinical spectrum of serious staphylococcal disease. Mortality was 21 per cent, lower than previously reported. Patients could be separated into two groups according to the presence of identifiable primary staphylococcal infections; 63 bacteremic patients had such lesions, the remaining 42 lacked them. The latter group contained 24 of 26 cases of endocarditis. Illnesses in that group were marked by the presence (in 38 of 42 patients) of staphylococcal foci occurring secondary to bacteremia. Such foci were responsible for five of seven instances of relapse or treatment failure encountered in that group. Secondary staphylococcal foci occurred in only five of 63 patients with primary infections, and the response of this group to conventional therapy for bacteremia was satisfactory. This study suggests that endocarditis has become an unusual complication of identifiable primary staphylococcal infection. A clinical classification based on the presence of such lesions therefore separates bacteremic patients likely to be cured by conventional antibiotic therapy (those with primary infections but no secondary foci) from others (those with secondary foci, suggesting endocarditis) who should receive a more prolonged course of antibiotics.

References (21)

  • C Watanakunakorn et al.

    Some salient features of Staphylococcus aureus endocarditis

    Am J Med

    (1973)
  • R Wilson et al.

    Fifteen years' experience with Staphylococcus septicemia in a large city hospital

    Am J Med

    (1957)
  • L Weinstein et al.

    Infective endocarditis—1973

    Prog Cardiovasc Dis

    (1973)
  • LE Cluff et al.

    Staphylococcal bacteremia and altered host resistance

    Ann Intern Med

    (1968)
  • RI Wise

    Modern managenent of severe staphylococcal disease

    Medicine (Baltimore)

    (1973)
  • HH Hussey et al.

    Septicemia and bacterial endocarditis resulting from heroin addiction

    JAMA

    (1944)
  • RA Olsson et al.

    Staphylococcal tricuspid endocarditis in heroin addicts

    Ann Intern Med

    (1962)
  • CE Cherubin et al.

    Infective endocarditis in narcotic addicts

    Ann Intern Med

    (1968)
  • KB Menda et al.

    Favorable experience with bacterial endocarditis in heroin addicts

    Ann Intern Med

    (1973)
  • RR MacGregor et al.

    Evaluation of positive blood cultures

    Arch Intern Med

    (1972)
There are more references available in the full text version of this article.

Cited by (203)

  • Hospital-acquired Staphylococcus aureus primary bloodstream infection: A comparison of events that do and do not meet the central line–associated bloodstream infection definition

    2016, American Journal of Infection Control
    Citation Excerpt :

    One reasonable assumption would be that non-CLABSIs are caused by a delay in diagnosis from an overlooked focus. A delay in recognition of infection has been considered a possible explanation because prior studies have shown an increase in complications, including endocarditis, with episodes of SA bacteremia with either an unknown portal of entry or community onset.11 Contrary to our findings, Fowler et al found long-term vascular access to be one risk for hematogenous complications from catheter-associated SA bloodstream infection.12

  • Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: New insights and evidence from the literature

    2015, Journal of Infection and Chemotherapy

  • Staphylococcus aureus Bacteremia, Risk Factors, Complications, and Management

    2013, Critical Care Clinics
    Citation Excerpt :

    The absence of an obvious source of bacteremia has been shown to serve an important predictor of subsequent complications. In a series of 281 patients with SAB, the incidence of a metastatic complication was 2.5-fold lower with an identifiable source of bacteremia than among patients without an apparent source.3,7 The presence of prosthetic devices is frequently implicated as the source for SAB, as well as being an important risk factor for the development of complicated course, with mortality rates of up to 18% and a relapse rate of 15%.8

  • Infectious disease emergencies: Frontline clinical pearls

    2012, Medical Clinics of North America

  • Endocarditis

    2012, Critical Care Secrets: Fifth Edition

  • Clinical significance and outcome of polymicrobial Staphylococcus aureus bacteremia

    2012, Journal of Infection
    Citation Excerpt :

    Staphylococcus aureus is a frequent cause of bacteremia, and S. aureus bacteremia (SAB) is associated with high rates of life threatening complications, with documented associated mortality rates of 20–40%.9,10 Polymicrobial SAB has been observed in 2–17% of patients with SAB.11,12 Although several studies have assessed patients with polymicrobial bacteremia,1,3–7,13–16 none, to our knowledge, has focused on polymicrobial SAB.

View all citing articles on Scopus
☆

This study was supported by Grant AI03456 from the National Institute of Allergy and Infectious Disease. This study was presented in part at the Annual Session of the American College of Physicians, San Francisco, California, April, 1975.

∗

Present address: Department of Medicine, University of Arkansas Medical Center, Little Rock, Arkansas 72201.

1

From the Department of Medicine, University of Washington, Seattle, Washington.

View full text
Copyright © 1976 Published by Excerpta Medica Inc.